BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25451009)

  • 1. Structure and function of Toll/interleukin-1 receptor/resistance protein (TIR) domains.
    Ve T; Williams SJ; Kobe B
    Apoptosis; 2015 Feb; 20(2):250-61. PubMed ID: 25451009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways.
    Narayanan KB; Park HH
    Apoptosis; 2015 Feb; 20(2):196-209. PubMed ID: 25563856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bioinformatic approach to the identification of bacterial proteins interacting with Toll-interleukin 1 receptor-resistance (TIR) homology domains.
    Turner JD
    FEMS Immunol Med Microbiol; 2003 Jun; 37(1):13-21. PubMed ID: 12770755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry.
    Snyder GA; Deredge D; Waldhuber A; Fresquez T; Wilkins DZ; Smith PT; Durr S; Cirl C; Jiang J; Jennings W; Luchetti T; Snyder N; Sundberg EJ; Wintrode P; Miethke T; Xiao TS
    J Biol Chem; 2014 Jan; 289(2):669-79. PubMed ID: 24275656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial TIR domains: not necessarily agents of subversion?
    Spear AM; Loman NJ; Atkins HS; Pallen MJ
    Trends Microbiol; 2009 Sep; 17(9):393-8. PubMed ID: 19716705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functions of plant TIR domains.
    Burch-Smith TM; Dinesh-Kumar SP
    Sci STKE; 2007 Aug; 2007(401):pe46. PubMed ID: 17726177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To con protection: TIR-domain containing proteins (Tcp) and innate immune evasion.
    Patterson NJ; Werling D
    Vet Immunol Immunopathol; 2013 Sep; 155(3):147-54. PubMed ID: 23871438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
    Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
    Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
    Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
    Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The STIR-domain superfamily in signal transduction, development and immunity.
    Novatchkova M; Leibbrandt A; Werzowa J; Neubüser A; Eisenhaber F
    Trends Biochem Sci; 2003 May; 28(5):226-9. PubMed ID: 12765832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins.
    Watters TM; Kenny EF; O'Neill LA
    Immunol Cell Biol; 2007; 85(6):411-9. PubMed ID: 17667936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Evolution of TIR-Domain Signalosomes.
    Nimma S; Gu W; Maruta N; Li Y; Pan M; Saikot FK; Lim BYJ; McGuinness HY; Zaoti ZF; Li S; Desa S; Manik MK; Nanson JD; Kobe B
    Front Immunol; 2021; 12():784484. PubMed ID: 34868065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, purification, and crystallization of Toll/interleukin-1 receptor (TIR) domains.
    Tao X; Tong L
    Methods Mol Biol; 2009; 517():81-8. PubMed ID: 19378015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins.
    Cirl C; Wieser A; Yadav M; Duerr S; Schubert S; Fischer H; Stappert D; Wantia N; Rodriguez N; Wagner H; Svanborg C; Miethke T
    Nat Med; 2008 Apr; 14(4):399-406. PubMed ID: 18327267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative and phylogenetic analyses of three TIR domain-containing adaptors in metazoans: implications for evolution of TLR signaling pathways.
    Wu B; Xin B; Jin M; Wei T; Bai Z
    Dev Comp Immunol; 2011 Jul; 35(7):764-73. PubMed ID: 21362440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
    Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
    J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards the structure of the TIR-domain signalosome.
    Nimma S; Ve T; Williams SJ; Kobe B
    Curr Opin Struct Biol; 2017 Apr; 43():122-130. PubMed ID: 28092811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.
    Xu Y; Tao X; Shen B; Horng T; Medzhitov R; Manley JL; Tong L
    Nature; 2000 Nov; 408(6808):111-5. PubMed ID: 11081518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of TIR domain of TLR6 reveals novel dimeric interface of TIR-TIR interaction for toll-like receptor signaling pathway.
    Jang TH; Park HH
    J Mol Biol; 2014 Sep; 426(19):3305-3313. PubMed ID: 25088687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A linker strategy for the production and crystallization of Toll/interleukin-1 receptor/resistance protein domain complexes.
    Williams SJ; Ve T; Kobe B
    Protein Eng Des Sel; 2015 May; 28(5):137-45. PubMed ID: 25777769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.